XML 41 R27.htm IDEA: XBRL DOCUMENT
v3.23.3

Financial Instruments and Derivatives (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2023
Fair Value Disclosures [Abstract] |
Effect of Derivative Instruments on Consolidated Statement of Operations | The tables below present the effect of the Company’s derivative financial instruments on the Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2023 and 2022 (dollars in thousands):
|  |  |  | Net Loss Reclassified from AOCL into Interest Expense |
|  | Location of Loss Reclassified |  | Three months ended September 30, |
Derivatives in Cash Flow Hedging Relationships |  | from AOCL into Income |  | 2023 |  |  | 2022 |
Terminated interest rate swaps |  | Interest expense |  | $ | (279 | ) |  | $ | (279 | )
|  |  |  | Nine months ended September 30, |
|  |  |  | 2023 |  |  | 2022 |
Terminated interest rate swaps |  | Interest expense |  | $ | (835 | ) |  | $ | (835 | )
|  |  |  | Loss Recognized in Earnings on Derivative |
|  | Location of Loss Recognized |  | Three months ended September 30, |
Derivative Not Designated as Hedging Instrument |  | in Earnings on Derivative |  | 2023 |  |  | 2022 |
Preferred stock embedded derivative |  | Other non-operating expense (income) |  | $ | (11,250 | ) |  | $ | (425 | )
|  |  |  | Nine months ended September 30, |
|  |  |  | 2023 |  |  | 2022 |
Preferred stock embedded derivative |  | Other non-operating expense (income) |  | $ | (1,863 | ) |  | $ | (10,364 | )

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4E -Publisher FASB -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4E Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4C -Publisher FASB -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4C Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4A -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4A + Details
Name: | us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration